Is norethindrone (progestin) effective as a form of birth control?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Norethindrone as Birth Control: Effectiveness and Considerations

Norethindrone progestin-only pills are effective as birth control with a typical use failure rate of approximately 6% (perfect use 0.2%) when taken consistently at the same time every day. 1

Mechanism of Action

Norethindrone progestin-only pills (POPs) prevent pregnancy through multiple mechanisms:

  • Suppressing ovulation in approximately half of users
  • Thickening cervical mucus to inhibit sperm penetration
  • Lowering mid-cycle LH and FSH peaks
  • Slowing ovum movement through fallopian tubes
  • Altering the endometrium 1

Effectiveness

  • Perfect use: 0.2% failure rate
  • Typical use: Approximately 6% failure rate 2
  • In a 5-year study with 168 women using norethindrone 0.35 mg daily, the effectiveness rate was:
    • Drug-effectiveness rate: 1.9 per 100 woman-years
    • Use-effectiveness rate: 2.5 per 100 woman-years 3

Administration Requirements

For maximum effectiveness, norethindrone must be taken:

  • At exactly the same time every day
  • Continuously with no interruption between pill packs
  • A backup method should be used for 48 hours if a pill is taken 3+ hours late 1

Safety Profile Advantages

Norethindrone POPs offer several safety advantages compared to combined hormonal contraceptives:

  • No increased risk of venous thromboembolism (VTE) - relative risk of 0.90 (95% CI 0.57–1.45) compared to non-users 4
  • No effect on blood pressure 4
  • Safe for women with contraindications to estrogen 4
  • Can be used by women with cardiovascular risk factors 4

Side Effects and Considerations

  1. Menstrual Changes:

    • Irregular bleeding patterns in up to 25% of users
    • Breakthrough bleeding, spotting, or changes in cycle length 4
  2. Metabolic Effects:

    • Minimal effect on lipid metabolism
    • HDL, HDL2, and apolipoprotein A-I and A-II may be decreased
    • No effect on total cholesterol, HDL3, LDL, or VLDL 1
  3. Other Considerations:

    • Small amounts of progestin pass into breast milk (1-6% of maternal plasma levels)
    • Rare cases of decreased milk production have been reported 1
    • Rapid return to fertility after discontinuation 1

Drug Interactions

Effectiveness may be reduced when co-administered with:

  • Rifampin
  • Anticonvulsants (barbiturates, phenytoin, carbamazepine, felbamate, oxcarbazepine, topiramate)
  • Griseofulvin
  • St. John's Wort
  • Certain anti-HIV protease inhibitors 1

Special Populations

  1. Women with cardiovascular risk factors:

    • POPs are safer alternatives to combined hormonal contraceptives 4
    • Table 14 from the American Heart Association shows no increased stroke risk with progestin-only methods 2
  2. Adolescents:

    • Safety and efficacy are the same for postpubertal adolescents as for adult women
    • Not indicated before menarche 1

Practical Considerations

  • Patient education about expected side effects before starting can improve adherence
  • Regular follow-up visits 1-3 months after initiation are recommended
  • Blood pressure monitoring is advised but less critical than with combined hormonal contraceptives 4

Pitfalls to Avoid

  1. Timing errors: Taking pills more than 3 hours late significantly reduces effectiveness
  2. Drug interactions: Certain medications can reduce effectiveness
  3. Inadequate counseling: Patients should be informed about irregular bleeding patterns to improve adherence
  4. Failure to use backup method: When pills are taken late or with interacting medications

Norethindrone POPs provide an effective contraceptive option with a favorable safety profile, particularly for women with contraindications to estrogen-containing contraceptives. The key to effectiveness is consistent daily administration at the same time.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Contraception with Progestin-Only Pills

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.